Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Drug Industry Urged To Look Away From U.S. To CIS Nations

This article was originally published in PharmAsia News

Executive Summary

India's pharmaceutical industry is expected to suffer more than any other sector under the new U.S. presidency of Barack Obama, according to Promed Group President Deepak Bahri. The group makes and markets branded and generic drugs globally. Bahri said the new administration is likely to clamp down on outsourcing to the Indian market and allow greater generics competition to Indian drugs in the United States. He also advised drug makers to focus more on the former Soviet countries that have formed the Commonwealth of Independent States, a group making major changes in old health care systems. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts